Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 5/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 8/20 | 0.38 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | ACP1 | P24666 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13870892 | 0.83 | PSMB5 (0.44) | NUDT1CNR2ARCYP1A2 | |
| SCHEMBL13870918 | 0.80 | NQO2 (0.38) | AR | |
| SCHEMBL13870902 | 0.80 | NUDT1 (0.44) | NUDT1CNR2ARTLR8 | |
| SCHEMBL13870912 | 0.77 | KMT2A (0.38) | ARTLR8CYP1A2 | |
| SCHEMBL13870915 | 0.77 | CYP17A1 (0.38) | ARTLR8 | |
| SCHEMBL13870900 | 0.76 | BCHE (0.41) | — | |
| SCHEMBL14500786 | 0.76 | NUDT1 (0.44) | NUDT1CYP1A2 | |
| SCHEMBL13870954 | 0.76 | AR (0.39) | NUDT1CNR2ARTLR8ACP1 | |
| SCHEMBL13870945 | 0.76 | RAD52 (0.41) | NUDT1DHFR | |
| SCHEMBL13870927 | 0.76 | KDM4E (0.51) | NUDT1DHFRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8956737-B2 | Red phosphorescent compound and organic electroluminescent device using the same | LG DISPLAY CO., LTD. (KR) | 2015-02-17 | — | — | US | disclosed |
| US-8956737-B2 | Red phosphorescent compound and organic electroluminescent device using the same | LG DISPLAY CO., LTD. (KR) | 2015-02-17 | — | — | US | disclosed |
| US-20090085476-A1 | RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2009-04-02 | — | — | US | disclosed |
| US-20090085476-A1 | RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090085476-A1 | RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | IK, G6PD, EYA2 | NUDT1 391/4885CNR2 4734/4885AR 1429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.